Celularity Inc. CELU
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.29% | -22.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.29% | -22.33% | |||
| Cost of Revenue | -80.31% | 88.88% | |||
| Gross Profit | 173.21% | -336.96% | |||
| SG&A Expenses | -39.16% | 61.87% | |||
| Depreciation & Amortization | 124.81% | -556.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -42.48% | 34.02% | |||
| Operating Income | 49.83% | -57.20% | |||
| Income Before Tax | 103.59% | -5.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 103.59% | -5.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 103.59% | -5.57% | |||
| EBIT | 49.83% | -57.20% | |||
| EBITDA | 54.72% | -70.21% | |||
| EPS Basic | 102.70% | 1.91% | |||
| Normalized Basic EPS | 105.30% | 21.26% | |||
| EPS Diluted | 102.33% | 1.91% | |||
| Normalized Diluted EPS | 105.09% | 21.26% | |||
| Average Basic Shares Outstanding | 2.16% | 8.00% | |||
| Average Diluted Shares Outstanding | 6.49% | 8.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||